Table 2.
Location/Country | Population | Age (years) |
Sample size | IgG+ | Cut off points | Study period | References |
---|---|---|---|---|---|---|---|
Oyo state, Nigeria | Reproductive age | 15–45 | 230 | 215 (93.4 %) | NR | 2002 | [53] |
Vom, Nigeria | 20–65 | 96 | 87 (90.6 %) | NR | NR | [54] | |
Kenya | Children | 4–20 | 498 | 398 (79.9 %) | NR | Feb–June 2005 | [12] |
Uganda | Adults | 20–62 | 311 | 309 (99.3 %) | NR | NR | [55] |
Bangui, Central Republic of Africa | Children | 1 month–15 | 395 | 218 (55.1 %) | ≥15 IU/ml | July–Dec2008 | [13] |
Algeria | Reproductive age | 15–49 | 834 | 572 (68.6 %) | >10 IU/ml | March 2005–March 2007 | [56] |
Senegal | Reproductive age | 15–45 | 3471 | 3127 (90 %) | >10 IU/ml | March–June 2002 | [57] |
Egypt | Women | 6–45 | Urban = 172 Rural = 426 |
Urban = 170 (98.8 %) Rural = 386 (90.6 %) Overall (96.3 %) |
>15 IU/ml | NR | [58] |
Lagos, Nigeria | HIV population | 18–60 | 80 | 59 (73.8 %) | NR | April 2011–May 2012 | [59] |
Morocco | Reproductive age | 15–39 | Urban = 502 Rural = 465 |
Urban = 427 (85.1 %) Rural = 379 (81.5 %) Overall (83.3 %) |
>8.6 IU/ml | 2000 | [60] |
Total | 84.8 % (55.1–99.3 %) |
NR not reported